Potassium News and Research RSS Feed - Potassium News and Research

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC). [More]
NRL scientists develop novel one-step process to form oxide nanoparticles

NRL scientists develop novel one-step process to form oxide nanoparticles

Scientists at the U.S. Naval Research Laboratory Materials Science and Technology Division have developed a novel one-step process using, for the first time in these types of syntheses, potassium superoxide (KO2) to rapidly form oxide nanoparticles from simple salt solutions in water. [More]
FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Silvergate Pharmaceuticals, Inc., focused on the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Epaned for the treatment of symptomatic heart failure and the treatment of asymptomatic left ventricular dysfunction (to decrease the rate of development of overt heart failure and to reduce hospitalization for heart failure). [More]
DaVita Kidney Care hosts online Google+ Hangout on Air

DaVita Kidney Care hosts online Google+ Hangout on Air

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, will host an online Google+ Hangout on Air called "Kidney Diet Tips: Diabetes Edition" on Monday, Sept. 8 at 5:00 p.m. PT/8:00 p.m. ET. [More]
Mice who have partial deficiency of gene SENP2 are more likely to develop seizures, sudden death

Mice who have partial deficiency of gene SENP2 are more likely to develop seizures, sudden death

A gene crucial for brain and heart development may also be associated with sudden unexplained death in epilepsy (SUDEP), the most common cause of early mortality in epilepsy patients. [More]
Mylan launches Potassium Chloride Extended-release Tablets

Mylan launches Potassium Chloride Extended-release Tablets

Mylan Inc. today announced that it has launched Potassium Chloride Extended-release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg), which is the generic version of Upsher-Smith's Klor-Con. [More]
New therapeutic drug may prevent respiratory depression in patients taking opioid medication

New therapeutic drug may prevent respiratory depression in patients taking opioid medication

People taking prescription opioids to treat moderate to severe pain may be able to breathe a little easier, literally. [More]
Study sheds new light on how carbon monoxide could help protect hearts against arrhythmias

Study sheds new light on how carbon monoxide could help protect hearts against arrhythmias

A study, funded by the British Heart Foundation and Medical Research Council, has shed new light on how carbon monoxide could be used to protect against life-threatening arrhythmias after a heart attack. [More]
Researchers show effects of increased and decreased sodium intake on blood pressure

Researchers show effects of increased and decreased sodium intake on blood pressure

Two reports from a global collaborative study involving hundreds of investigators from 18 countries published today in the New England Journal of Medicine are shaking up conventional wisdom around salt consumption. [More]
Almonds can help reduce inflammation in people with poorly controlled diabetes

Almonds can help reduce inflammation in people with poorly controlled diabetes

Evidence continues to mount supporting the role of almonds and other tree nuts as part of an overall dietary pattern that is beneficial for those with type 2 diabetes. Three new studies suggest a relationship between regular consumption of tree nuts, such as almonds, and improvement in various markers of health in type 2 diabetes. [More]
Experts examine how molecule in parasitic worms can effectively treat autoimmune diseases

Experts examine how molecule in parasitic worms can effectively treat autoimmune diseases

Experts believe a molecule in parasitic worms could help explain why worm infections can effectively treat a range of autoimmune diseases, including multiple sclerosis, psoriasis, rheumatoid arthritis and lupus. [More]
Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes. [More]
Eating pistachios may reduce body's response to stresses among adults with diabetes

Eating pistachios may reduce body's response to stresses among adults with diabetes

Among people with type 2 diabetes, eating pistachios may reduce the body's response to the stresses of everyday life, according to Penn State researchers. [More]
Eating beans, peas, chickpeas can increase fullness, may lead to better weight management

Eating beans, peas, chickpeas can increase fullness, may lead to better weight management

Eating about one serving a day of beans, peas, chickpeas or lentils can increase fullness, which may lead to better weight management and weight loss, a new study has found. [More]
Consumer education campaign can help explain eventual changes to food labels

Consumer education campaign can help explain eventual changes to food labels

To help Americans make better decisions about what they eat, the Food and Drug Administration (FDA) earlier this year proposed significant changes to the Nutrition Facts label found on nearly every food product in the U.S. [More]
Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

Bayer HealthCare and Onyx Pharmaceuticals Inc., an Amgen subsidiary, today announced that an investigational Phase 3 trial of NEXAVAR (sorafenib) tablets in patients with advanced breast cancer did not meet its primary endpoint of improving progression-free survival (PFS). [More]
Potassium supplements with loop diuretics increase survival rates of heart failure patients

Potassium supplements with loop diuretics increase survival rates of heart failure patients

Researchers from the Perelman School of Medicine at the University of Pennsylvania found that patients taking prescription potassium supplements together with loop diuretics for heart failure have better survival rates than patients taking diuretics without the potassium. Moreover, the degree of benefit increases with higher diuretic doses. [More]
Study of cancer radiation therapy shows that DNA building blocks are susceptible to fragmentation

Study of cancer radiation therapy shows that DNA building blocks are susceptible to fragmentation

A new study relevant for cancer radiation therapy shows that DNA building blocks are susceptible to fragmentation. Scientists now have a better understanding of how short DNA strands decompose in microseconds [More]
Healthy lifestyle helps hard-to-treat hypertensive patients

Healthy lifestyle helps hard-to-treat hypertensive patients

Maintaining a healthy lifestyle can prevent cardiovascular events even among patients with apparent treatment-resistant hypertension, say researchers. [More]
Dyadic International announces details regarding new Bakenzyme project

Dyadic International announces details regarding new Bakenzyme project

Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today details regarding its new Bakenzyme project. [More]